JW Cayman Therapeutics Files Director List with HKEX

Reuters

Dec 12, 2025

JW Cayman <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Files Director List with HKEX

JW (Cayman) Therapeutics Co. Ltd. has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Dr. Cheng Liu (Chairman), Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song as Non-executive Directors, alongside Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships were also disclosed: Mr. Ho serves as Chairman of both the Audit and Nomination Committees, with Dr. Yu chairing the Remuneration and Business Development and Strategy Committees. Ms. Gao and Mr. Chan are members of the Audit Committee, while Dr. Song is a member of the Remuneration Committee. Dr. Yu and Ms. Gao are members of the Business Development and Strategy Committee and Remuneration Committee, respectively.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251212-11953206), on December 11, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2590476205"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2590476205\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2590476205?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 07:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590476205","market":"us","top_or_hot":-1,"title":"JW Cayman Therapeutics Files Director List with HKEX","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      JW Cayman <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        JW (Cayman) Therapeutics Co. Ltd. has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Dr. Cheng Liu (Chairman), Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song as Non-executive Directors, alongside Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships were also disclosed: Mr. Ho serves as Chairman of both the Audit and Nomination Committees, with Dr. Yu chairing the Remuneration and Business Development and <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> Committees. Ms. Gao and Mr. Chan are members of the Audit Committee, while Dr. Song is a member of the Remuneration Committee. Dr. Yu and Ms. Gao are members of the Business Development and <a href=\"https://laohu8.com/S/STRF\">Strategy</a> Committee and Remuneration Committee, respectively.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251212-11953206), on December 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JW Cayman Therapeutics Files Director List with HKEX</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJW Cayman Therapeutics Files Director List with HKEX\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-12 07:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      JW Cayman <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        JW (Cayman) Therapeutics Co. Ltd. has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Dr. Cheng Liu (Chairman), Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song as Non-executive Directors, alongside Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships were also disclosed: Mr. Ho serves as Chairman of both the Audit and Nomination Committees, with Dr. Yu chairing the Remuneration and Business Development and <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> Committees. Ms. Gao and Mr. Chan are members of the Audit Committee, while Dr. Song is a member of the Remuneration Committee. Dr. Yu and Ms. Gao are members of the Business Development and <a href=\"https://laohu8.com/S/STRF\">Strategy</a> Committee and Remuneration Committee, respectively.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251212-11953206), on December 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL8HV5Jx:1","article_id":"2590476205","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590476205","pubTimestamp":1765496054,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"JW  Therapeutics Co. Ltd. has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Dr. Cheng Liu , Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song as Non-executive Directors, alongside Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships were also disclosed: Mr. Ho serves as Chairman of both the Audit and Nomination Committees, with Dr. Yu chairing the Remuneration and Business Development and Strategy Committees. Ms. Gao and Mr. Chan are members of the Audit Committee, while Dr. Song is a member of the Remuneration Committee. Dr. Yu and Ms. Gao are members of the Business Development and Strategy Committee and Remuneration Committee, respectively.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","BK1574":"生物医药B类股","02126":"药明巨诺-B","BK1583":"高瓴概念"},"translate_title":"JW Cayman Therapeutics向港交所提交董事名单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02126":0.9},"content_text":"JW Cayman Therapeutics Files Director List with HKEX\n    \n\n        JW (Cayman) Therapeutics Co. Ltd. has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Dr. Cheng Liu (Chairman), Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song as Non-executive Directors, alongside Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships were also disclosed: Mr. Ho serves as Chairman of both the Audit and Nomination Committees, with Dr. Yu chairing the Remuneration and Business Development and Strategy Committees. Ms. Gao and Mr. Chan are members of the Audit Committee, while Dr. Song is a member of the Remuneration Committee. Dr. Yu and Ms. Gao are members of the Business Development and Strategy Committee and Remuneration Committee, respectively.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251212-11953206), on December 11, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}